https://biotechmorning.com/news/alamar-biosciences-ipo-oversubscribed Biotech Morning en 2026-04-25T14:09:15.651Z The Protein-Reading Company Wall Street Couldn't Get Enough Of https://biotechmorning.com/news/white-house-fda-fast-track-psychedelics Biotech Morning en 2026-04-25T14:08:32.930Z The White House Just Told the FDA to Fast-Track Psychedelics https://biotechmorning.com/news/kailera-therapeutics-ipo-breaks-nasdaq-record Biotech Morning en 2026-04-25T14:07:51.913Z The $625M IPO That Just Broke Nasdaq Biotech Records https://biotechmorning.com/news/wcg-acquires-contract-network-clinical-trials Biotech Morning en 2026-04-25T14:07:12.640Z The Boring Part of Clinical Trials Just Got a Makeover https://biotechmorning.com/news/amneal-kashiv-biosimilar-manufacturing-deal Biotech Morning en 2026-04-25T14:06:33.300Z Amneal Just Bet $1.1 Billion That Making Biosimilars Is the Real Gold Rush https://biotechmorning.com/news/fda-fast-tracked-psychedelics-priority-review Biotech Morning en 2026-04-25T14:05:50.054Z The FDA Just Fast-Tracked Psychedelics. Yes, Really. https://biotechmorning.com/news/helus-pharma-ceo-exit-two-months Biotech Morning en 2026-04-24T14:09:50.103Z Two Months and Out: The CEO Exit That Has Biotech Investors Nervous https://biotechmorning.com/news/regeneron-first-gene-therapy-approval-hearing-loss Biotech Morning en 2026-04-24T14:09:08.109Z Regeneron Just Cured a Type of Deafness With a Single Surgery https://biotechmorning.com/news/pfizer-cancer-campaign-fernando-mendoza Biotech Morning en 2026-04-24T14:08:26.720Z Why Pfizer Just Bet Its Cancer Brand on a Rookie Quarterback https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-drugs Biotech Morning en 2026-04-24T14:07:43.525Z The $200M Bet That You've Been Taking Your Lung Drugs Wrong https://biotechmorning.com/news/regeneron-last-holdout-white-house-drug-pricing-deal Biotech Morning en 2026-04-24T14:06:57.128Z Regeneron Was the Last Holdout. The White House Just Got Its Deal.